FOLH1 and Familial prostate cancer: Between January 2009 and April 2019, 86 patients with BF after primary local therapy for prostate cancer had FCH PET/CT or PSMA PET/CT, on which only nodal relapses were diagnosed (82 using FCH PET/CT and 4 using PSMA PET/CT).